News & Updates
Filter by Specialty:
Shorter treatment regimen feasible for rifampin-resistant TB?
13 Feb 2023
byAudrey Abella
Individuals with rifampin-resistant tuberculosis (RR-TB) may have the option to undergo shorter treatment periods, as findings from the phase II/III TB-PRACTECAL* trial show the noninferiority and superiority of a 24-week, all-oral regimen to standard of care (SoC). It also had a better safety profile than SoC.
Shorter treatment regimen feasible for rifampin-resistant TB?
13 Feb 2023T2D, orthostatic hypotension up risks of falls, in-hospital mortality
12 Feb 2023
The risk of falls is higher among sedentary patients and those with lower Timed Up and Go test (TUG), according to a study. Patients with type 2 diabetes (T2D) are also at increased risk of falls.